# Optimal Blood Pressure Treatment Thresholds Postpartum

> **NCT06069102** · PHASE4 · COMPLETED · sponsor: **Alisse Hauspurg** · enrollment: 61 (actual)

## Conditions studied

- Hypertensive Disorder of Pregnancy
- Pre-Eclampsia
- Hypertension
- Eclampsia
- Gestational Hypertension
- Cardiovascular Diseases
- Toxemia
- Pregnancy Complications
- Vascular Diseases
- Hypertension, Pregnancy Induced
- Hypertension;Pre-Eclamptic

## Interventions

- **DRUG:** Usual care
- **DRUG:** Tight blood pressure control

## Key facts

- **NCT ID:** NCT06069102
- **Lead sponsor:** Alisse Hauspurg
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-15
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06069102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06069102, "Optimal Blood Pressure Treatment Thresholds Postpartum". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06069102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*